Type 2 Diabetes

Use of SGLT2 inhibitors was associated with improved kidney health among a diverse multiethnic cohort of Asian adults with type 2 diabetes, researchers found in a retrospective cohort study.

Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a DPP-IV inhibitor, according to findings published in Thyroid.

Pregnant women with type 2 diabetes have a greater risk for perinatal mortality vs. pregnant women with type 1 diabetes, gestational diabetes and no diabetes, researchers reported in the American Journal of Obstetrics and Gynecology.

Younger age at type 2 diabetes diagnosis was significantly associated with elevated dementia risk, especially for individuals with obesity, according to results published in PLOS One.

New guidance on GLP-1 receptor agonist use, how to tackle medication shortages and expanded continuous glucose monitoring use for type 2 diabetes are among the updates in the American Diabetes Association’s 2025 Standards of Care.

In patients with hypercortisolism and difficult-to-control type 2 diabetes, mifepristone lowered HbA1c at 24 weeks compared with placebo, researchers reported at World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.

Individuals with diabetes who were hospitalized for non-ST elevation myocardial infarction had significantly higher risk for long-term mortality compared with individuals without diabetes, according to new research.

The FDA approved a generic version of the GLP-1 receptor agonist liraglutide to improve glycemic control for people with type 2 diabetes, according to a press release from the agency.

Continuous glucose monitoring can lower mortality risk in addition to improving glycemic control for people with diabetes, according to a speaker at the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.

Patients with type 2 diabetes uncontrolled by metformin who received pioglitazone and insulin demonstrated increased risk for ischemic heart disease, according to findings published in the Journal of Diabetes and Its Complications.